Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

Article Abstract:

A study was conducted to show that CD44 is a key regulator of acute myeloid leukemia-leukemia stem cells (AML LSC) function that is essential for proper homing of AML-LSCs to microenvironmental niches and for maintaining AML LSCs in primitive state. Manipulation of CD44 function with the H90 mAb resulted in marked reduction of the leukemic burden in NOD-SCID mice transplanted with primary AML cells and it is possible to target AML LSCs by focusing on their stem cell properties rather than proliferation.

Author: Dick, John E., Liqing Jin, Hope, Kristin J., Qiongli Zhai, Smadja-Joffe, Florence
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2006
Care and treatment, Causes of, Stem cells

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells

Article Abstract:

A study was conducted to show that CD44 expression is increased on mouse stem-progenitor cells expressing BCR-ABL and that CD44 contributes functional E-selection ligands. The results show that BCR-ABL-expressing leukemic stem cells depend to a greater extent on CD44 for homing and engraftment than do normal hematopoietic stem cells (HSCs), and CD44 blockage might be beneficial in autologous transplantation in chronic myeloid leukemia (CML).

Author: Van Etten, Richard A., Krause, Daniela S., von Andrian, Ulrich H., Lazarides, Katherine
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2006
Hematopoietic stem cells, CD4 lymphocytes, Leukemia research

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia

Article Abstract:

Ligation of CD44 with specific anti-CD44 monoclonal antibodies or with hyaluronan has been found to be able to reverse myeloid differentiation blockage in acute myeloid leukemia (AML)1/2 - AML5 subtypes. Hyaluronan is the natural ligand of CD44. Differentiation of AML blasts was seen from expression of lineage antigens, ability to bring oxidative bursts, and cytological changes. These are specific to normal differentiated myeloid cells.

Author: Chomienne, Christine, Smadja-Joffe, Florence, Li, Yue, Charrad, Rachida-Sihem, Delpech, Bertrand, Balitrand, Nicole, Clay, Denis, Jasmin, Claude
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 1999
France, Physiological aspects, Glycoproteins, Lymphocyte transformation, Cell differentiation, Monoclonal antibodies, Hyaluronic acid, Cell research, Cytological research, Acute leukemia, Promyelocytic

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Research, United States, Acute myelocytic leukemia
Similar abstracts:
  • Abstracts: Does this patient with diabetes have osteomyelitis of the lower extremity? Does this patient have hearing impairment?
  • Abstracts: Prevalence of infective endocarditis in patients with systemic lupus erythematosus. The efficiency of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures
  • Abstracts: Gastrointestinal tract. The management of animal and human bite wounds
  • Abstracts: Ethanol stimulation of HIV infection of oral epithelial cells
  • Abstracts: Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. Efficacy of lenalidomide in myelodysplastic syndromes
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.